Aarti Drugs Ltd - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates / Issue of Duplicate Share Certificates under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Aarti Drugs Ltd - 524348 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Aarti Drugs Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here AARTI DRUGS LTD. - 524348 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
This has reference to 34th AGM of the Company which was held on Tuesday, August 6, 2019 at 11:30 AM. We are enclosing herewith the scrutinizer's report and voting results of the AGM. Aarti Drugs Ltd - 524348 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting details of the proceedings of 34th Annual General Meeting of the Company held at TIMA Hall, MIDC Tarapur, Dist. Palghar 401 506, Maharashtra on Tuesday, August 6, 2019 at 11:30 AM AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates / Issue of Duplicate Share Certificates under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith copy of the press release issued by the Company on July 29, 2019. Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform you that Quarterly conference Call for Investors and Analysts has been scheduled on Monday, July 29, 2019 at 4:00 PM IST to discuss the Company's Q1 FY20 Results. Please find attached herewith invitation for the same. Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Credit Rating
Please note that CRISIL has recently reviewed the Credit Rating and upgraded the Long-Term Rating from 'CRISIL A/Positive' to 'CRISIL A+/Stable' Aarti Drugs Ltd - 524348 - Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2019
We wish to inform you that Board of Directors at its Meeting held on Friday, July 26, 2019, approved the Audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2019. Aarti Drugs Ltd - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates / Issue of Duplicate Share Certificates under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015